Soft Tissue Allografts Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

The global market for soft tissue allografts is expected to grow at a CAGR of 7.5% during the forecast period of 2022 to 2030. In addition, the industry had a revenue of approximately US $4.2 billion in 2021. The expansion of the market can mostly be ascribed to the rising number of people who have been injured in accidents and the growing elderly population. According to projections made by the World Health Organization (WHO), the total number of individuals aged 60 and older across the globe would reach 1.4 billion by the year 2030. The advancement of technology has contributed to the rise in the popularity of soft tissue allografts. The need for sterile tissue allografts is being driven by a number of factors, including an ageing population, an increase in the demand for soft tissue allografts in athletics, growth in the number of tissue banks, and an increase in the number of orthopaedic surgical procedures. The majority of corporations are making preparations to introduce items that are soft tissue allografts. It is anticipated that an increase in awareness will assist in the expansion of the market for soft tissue allografts worldwide. Significant strides have been made in the education of patients, which can be attributed in part to the expansion of Internet access and the proliferation of social media platforms. It is anticipated that an increase in consumers' understanding of products and methods will be beneficial to the global market for soft tissue allografts. In addition, it is anticipated that underlying healthcare trends, the rise in the importance of sports, and the rise in the population of elderly people would drive expansion in the global market.

Market To Be Driven by Clinical Applications in Medical Procedures and Sports Injuries

Athletes competing in modern athletics, field events, and a variety of other contact sports, such as American football, are required to take part in hard training sessions that are frequently more taxing than the sport itself. However, excessive training creates exhaustion in the muscles and bones and frequently leads to injuries. High-intensity training regimens are closely associated with enhanced athletic performance; however, excessive training does not improve athletic performance. Accidents, impacts, bad training habits, a lack of conditioning, inappropriate equipment, inadequate warm-up and stretching, and other factors can all contribute to the development of sports injuries. Injuries among young people are on the rise as a direct result of their participation in a single sport for the entire year. The American Academy of Paediatrics estimates that around 30 million children and teenagers in the United States participate in organized sports each year, which results in more than 3.5 million injuries. One-third of all injuries sustained by children occur as a result of participation in sports.

The Global Market Is Expected to Expand as A Result of The Growing Number of Orthodontic and Dental Cases Associated with Ageing

People of advanced age have a greater risk of sustaining damage to their soft tissues. People naturally become slower as they age, and have less energy, and less power as they progress through the years. Because of this, individuals are more likely to sustain injuries. People aged 65 and older have a higher risk of dying from falls than any other cause. It is by far the most typical cause for older patients to check themselves into the emergency room. The elderly population has a higher prevalence of tooth loss, which can be brought on by either disease or trauma. The use of dental implants as a means of providing support for the replacement of missing teeth has a lengthy and intricate history. In the most recent few years, there has been a growth in research on dental implant designs, materials, and methods. It is anticipated that it will go up in the not-too-distant future as a result of the expansion of the market for dental implants and the growing interest in cosmetic dentistry. It is anticipated that this will drive the size of the soft tissue allografts market in the not-too-distant future.

Increasing Prevalence of Osteoarthritis

Osteoarthritis has a significant effect on the individual patient, causing them to suffer from pain and incapacity; as a result, the market is anticipated to experience growth in the not-too-distant future due to the growing prevalence of this condition. For instance, according to the statistics compiled by the National Health Service of the United Kingdom in the year 2020, tennis elbow was a prevalent condition that affected approximately 1% to 3% of the population, which corresponds to approximately 4 to 7 cases per 1,000 people each and every year. The market for soft tissues is beginning to establish its footing because of technological advancement. There are a lot of businesses on the market today that have the goal of launching items that will contribute to the expansion of the market; however, the expansion of consumers' knowledge and awareness of these products will also play a significant role. The general public now has a higher degree of knowledge, which can be attributed in large part to the expansion of Internet access and the simplification of access to social media. Growing familiarity with both products and production methods will prove beneficial to the market for soft tissue over the course of time.

Other Causes Boosting the Need for Soft Tissue Allografts

• An Increase in the Number of Victims of Trauma - The World Health Organization estimates that about 1.3 million people lose their lives too soon as a direct result of being involved in a traffic collision every single year. Between 20 and 50 million people in the world are incapacitated as a direct result of non-fatal injuries, and the majority of these people are unable to work.
• An increasing number of people are suffering from musculoskeletal conditions, which affect around 1.71 billion people all over the world.
• Increasing Incomes Per Person According to the World Bank, the yearly global per capita revenue climbed by 4.8% in 2021, which is a significant improvement from the 1.5% gain seen in 2019.

Dental Allograft Dominated the Market in 2021

The allograft market can be segmented into Dental Allograft, Tendon Allograft, Cartilage Allograft, Meniscus Allograft, and Other Allografts, depending on the type of product that is being sold. Dental allograft dominated the market in 2021. In the majority of cases, a dental bone transplant is performed after extraction in order to preserve the edentulous area in preparation for the insertion of an implant. Following tooth extraction, ridge augmentation and socket preservation are procedures that are carried out in order to reduce the amount of significant bone loss and anomalies. By employing a bone transplant, ridge augmentation has the potential to restore both the height and width of lost bone, while also preventing additional bone loss. The process of filling an extraction socket with bone or a bone substitute during a treatment known as socket preservation can improve the likelihood of success for subsequent dental surgeries such as dental implants, dentures, or bridges. When upper posterior teeth are taken, the floor of the maxillary sinus may become loose and fall out, leaving behind only a little quantity of bone.

Cartilage Allograft to Lead the Growth During the Forecast Period

Patients who are missing cartilage or osteochondral tissue have a number of therapy options available to them, one of which is an osteochondral allograft, or OCA, transplantation. For instance, one study titled Osteochondral Allograft Transplant for Focal Cartilage Defects of the Femoral Condyles: Clinically Significant Outcomes, Failures, and Survival at a Minimum 5-Year Follow-up found that osteochondral transplant demonstrates significant clinical improvement and durability at mid-to-long-term follow-up, with 5 and 10-year survival rates of 86.2% and 81.8%, respectively. The study was conducted as a result, and the enhanced effectiveness of OCA will be the driving force behind the segmental expansion.

In orthopaedic surgery operations such as joint repair and other similar procedures, cartilage allografts are an essential component. In the treatment of chondral and osteochondral lesions, particularly those that occur in the knee, cartilage graft transplantation is a procedure that is utilized regularly. These procedures have the potential to improve one's quality of life and decrease symptoms for those who suffer from a condition that affects the cartilage found within the joints. Osteochondral allograft (OCA) is a procedure that involves the transplantation of fully developed or mature hyaline (joint) cartilage that contains living cartilage cells (known aschondrocytes). These cartilage cells are able to survive the transplant and continue to support the production of the cartilage matrix indefinitely after the procedure.

Hospital Remained the Dominant End-Use Segment

Hospitals account for the largest share of the market in 2021. Soft tissue allograft is utilized by specialists in clinics for the purpose of shoulder repair, spinal fusion, knee and ankle joint reconstruction, meniscal replacement, reconstruction as a result of cancer or damage, ridge augmentation in dental procedures, and urological operations. Repair of the anterior cruciate ligament (also known as ACL) is one of the most common orthopaedic surgeries, with more than 200,000 procedures carried out each year at a rate ranging from 30 to 78 per 100,000 people. ACL reconstruction techniques have evolved over the course of time, transitioning from open surgeries that restricted postoperative weight-bearing and range of motion to arthroscopically assisted single-incision approaches that enabled patients to immediately resume full weight-bearing and range of motion. In a similar vein, there has been a fundamental shift in the selection of grafts.

North America Remains as the Global Leader

In 2021, the market for soft tissue allografts was led by North America. Because of the presence of important players and the region's high rate of technology adoption, it is expected that the market in this region will develop at the highest CAGR during the forecast period of 2022 to 2030. Additionally, the prevalence of diabetic foot ulcers, improvements in diabetes healthcare awareness initiatives, and an increase in the number of surgical procedures are all contributing factors that are expanding the market share of soft tissue allografts in North America. It is anticipated that market expansion will be driven by the introduction of new products in the region. For instance, the Food and Drug Administration of the United States (FDA) received marketing authorisation for an anterior cruciate ligament (ACL) implant in December 2020. This implant was designed to serve as an alternative to ACL reconstruction in the treatment of ACL rupture. In the treatment of ACL ruptures, this device can be used to reconstruct the ligament using an allograft, an auto graft, or just sutures alone.

In addition, the report entitled Canadian Institute for Health Information 2020 found that the number of Canadians who have undergone joint replacement surgery has increased over the course of the previous five years, with 138,000 operations being carried out annually. In the 2019 - 2020 medical year, there were approximately 63,000 hip replacements and 75,000 knee replacements carried out in Canada. As a result, the increasing number of hip and knee replacements performed in Canada is anticipated to drive the market for soft tissue allografts because these products are utilized in surgical procedures. Therefore, the growing burden of diseases is producing the huge potential for market players, and these market players are focusing their efforts on research and development activities in order to provide new and trustworthy products into the market, which is driving the expansion of the market. For instance, in February 2020, Integra LifeSciences Holding Corporation introduced AmnioExcel Plus Placental Allograft Membrane as their most recent wound care offering to enhance soft tissue recovery. This particular product was developed by the company. As a consequence of this, thanks to the aforementioned factors, it is anticipated that the market would have a high growth rate throughout the course of the forecast year.

Product Launches Remain as the Key Strategy to Combat Intensifying Competition

The market for soft tissue allografts is moderately competitive, and a large number of international players are currently active within the market. Abbvie Inc. (Allergan), Conmed Corporation, Becton Dickinson and Company, Smith & Nephew (Osiris Therapeutics Inc.), Integra LifeSciences Corporation, Stryker Corporation, Zimmer Biomet, Arthrex Inc., and Direct Biologics are some of the companies that compete in this industry. Additionally, new product launches by these players are contributing to an increase in demand for the aforementioned products. There are a large number of key players in the global soft tissue allografts market, which contributes to the market's fragmentation. The most important strategies that the dominant players have implemented thus far include expanding their product lines and engaging in mergers and acquisitions.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Soft Tissue Allografts market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Soft Tissue Allografts market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

• Cartilage Allografts
• Hyaline Cartilage
• Elastic Cartilage
• Fibro Cartilage
• Tendon Allografts
• Achilles Tendon
• Tibialis
• Patellar Tendon
• Hamstring
• Meniscus Allografts
• Dental Allografts
• Free Gingival Graft
• Connective Tissue Graft
• Pedicle Graft
• Collagen Allografts
• Amniotic Allografts

Application

• Orthopedic
• Sports Medicine
• Spine Surgeries
• General Orthopedic
• Reconstruction
• Dentistry
• Dental Sensitivity
• Aesthetics
• Wound Care
• Others

End-user

• Hospitals
• Orthopedic Clinics
• Dental Clinics
• Ambulatory Surgical Centers
• Aesthetic Centers

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Soft Tissue Allografts market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2030.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Soft Tissue Allografts market?
• Which is the largest regional market for Soft Tissue Allografts market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Soft Tissue Allografts market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Soft Tissue Allografts market worldwide?

This product will be delivered within 2 business days.